ATLAS Market profile
Menu
Atlas · Symbols · Stocks & Shares · CTRE

Atlas market file · Equity · United States

CareTrust REIT, Inc.CTRE

Last close
41.13
Change
-0.02%
96-bar range
35.65 – 43.62
As of
6 Aug 2026

CareTrust REIT, Inc. is a real estate investment trusts issuer listed as CTRE on NYSE. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.

Identity
Nasdaq Trader
Chart rail
TradingView
File state
Public profile
Atlas chart snapshot NYSE:CTRE

Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.

43.859141.74739.63537.52335.410920 Mar29 May06 Aug

up candle   down candle

Latest close41.13
Day change-0.02%
Window high43.62
Window low35.65
96-bar change+13.93%
SnapshotDaily · 96 bars
As of2026-08-06 13:30 UTC

Weekly outlook: the last 104 weekly closes (+40.81% over the window).

43.982824.197219 Aug06 Aug

Source rail: Yahoo Finance chart API (CTRE). This dated snapshot is the crawlable Atlas reference.

Live market viewTradingView · provider feed Open view

Open the attributed TradingView market view for CTRE. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.

Loading the attributed market view...

Open full TradingView chart ->

Atlas Pro artifact

CTRE Market Snapshot PDF

Evidence checks passed

The latest snapshot audit passed. Atlas checks entitlement and evidence again when the PDF is requested.

Snapshot2-page artifact
Evidence audit2026-07-13
Research PDFNot in archive

Atlas Pro entitlement required. The release gate runs again when you request the file.

At a glance

CTRE public profile

Company

Real estate investment trusts issuer. CareTrust REIT, Inc. is connected to current market context, cited company sources and its retained research file.

Market

CareTrust REIT, Inc. trades as CTRE on NYSE. CareTrust REIT, Inc. (CTRE) has a latest verified close of 41.13, down 0.02%, dated 6 Aug 2026.

Research

Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. Atlas files CTRE under USA Stocks, Healthcare & Medicine Stocks and Financial Stocks for browsing.

Institutional Market Wit ● Sourced Research File

CareTrust REIT's latest balance sheet is the kind of document that makes spreadsheets weep with envy. The company reported $142.8 million in revenues for the quarter ending 31 March 2026, but tucked inside that number is a far more interesting figure: $3.9 million in *revenue from contracts with customers, excluding assessed tax*. That's the kind of line item that usually gets filed in the footnotes, where it belongs, because it's the bit that doesn't quite match the glossy brochures. The glossy brochures, by the way, promise to help "top-notch healthcare operators realise their growth potential" while delivering "steady value to shareholders". One of those things is audited; the other is a slide deck. (source: 10-Q, period ending 2026-03-31...

Unlock 25 custom research runs/day, 104-week candle charts, PDF report downloads & 500-symbol watchlist.

Unlock Atlas Pro — £12/mo Open Free Workstation Run →
Daily answer

What changed for CareTrust REIT, Inc. today

Open full report
CTRE daily contextvalidated public digest12 source rail2026-08-07 02:40 UTC

CareTrust REIT, the real-estate investment trust that leases senior housing and healthcare properties to operators across the country, reported $142.8 million in revenues for the quarter ended 31 March 2026, alongside $80.2 million in net income and $0.36 in diluted earnings per share. The company also disclosed $223.2 million in cash and cash equivalents, $5.24 billion in total assets, and $1.08 billion in liabilities, leaving $4.13 billion in stockholders’ equity. The numbers are audited; the marketing is aspirational.

CareTrust’s public story is all about enabling “top-notch healthcare operators” while delivering “steady value to shareholders,” according to its official site. The company selects operators who “bring a scoreboard of quality results” and “create a positive culture for their employees,” a pitch that sounds like a healthcare incubator, not a landlord. The image library even features a cheerful seniors’ residence called Willow Knoll, which is lovely, but it doesn’t alter the fact that CareTrust’s main product is long-term leases to operators whose performance it cannot directly control. The company’s own filings make clear that its growth depends on the financial health of its tenants, not its own operating leverage.

The latest 10-Q for the quarter ending 31 March 2026 shows $142.8 million in revenues, $80.2 million in net income, $0.36 diluted EPS, and $90.4 million in net cash provided by operating activities. The balance sheet clocked $5.24 billion in assets against $1.08 billion in liabilities, with equity at $4.13 billion. Cash and equivalents stood at $223.2 million, and weighted average diluted shares outstanding were 224.0 million. The numbers are concrete; the story is human resources theatre.

May 2026 brought a flurry of filings: two 424B5 shelf registrations reserving 3,170,629 shares for future grants and issuance, and a pair of 8-Ks on 20-21 May announcing the same. The shelf filings also note that net operating losses or capital losses carried forward could reduce the cash distributions needed to satisfy REIT requirements, a reminder that the company’s cash flow can be turbocharged by tax history rather than operating performance. The 8-Ks themselves are light on detail beyond the shelf announcements, which is par for the course when the news is mostly about filing trail.

The company’s governance angle is visible via a 13G/A filed on 15 May 2026, which is standard fare for passive holders and does not signal activism or a change of control. The broader picture is one of a cash-generative REIT whose growth prospects are tethered to the fortunes of its tenant operators, whose quality metrics it highlights but whose financials it cannot audit. The evidence does not include segment-level revenue splits, same-store metrics, or forward guidance; what we have is a balance sheet that works and a marketing story that glows.

If you want to see the official pitch, the company’s “What We Do” page and image library are here: https://www.caretrustreit.com/what-we-do. The leadership page is here: https://www.caretrustreit.com/leadership. The entire SEC filing index is here: https://www.sec.gov/edgar/browse/?CIK=1590717. For the raw company facts JSON, see: https://data.sec.gov/api/xbrl/companyfacts/CIK0001590717.json.

Sources & evidence · 10 links

This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.

Ticker
CTRE
Exchange
NYSE
Sector
Us Public Equity Directory
Region
United States
Asset class
Equity
Directory source
Nasdaq Trader
SEC CIK
TradingView

CTRE technical readout

Trend strength (ADX 14)
28.1
Average true range (ATR 14)
1.0279
ATR as % of price
2.41%
Volatility compression (ATR14/ATR50)
1.03x

Directional bias up. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.

Source authority

CTRE evidence rails

Atlas uses the specific public rails available for CTRE: SEC EDGAR, Nasdaq Trader, TradingView, FRED. Source names identify the public evidence trail; no partnership, sponsorship or endorsement is implied.

Sources & evidence · 5 rails

Open an Atlas research path on CTRE

FreedomCore Atlas can expand this public profile into source-led research files with company snapshots, valuation context, filings and segment detail, source packs, and equity briefs. Each path keeps the underlying public sources visible.

Open Atlas workstation ->
📄
Institutional Research PDF Available for CTRE Verified 104-week candle chart, SEC filing evidence & risk register.
Download PDF
Atlas Pro

Keep CTRE research in your Atlas archive

Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.

Checking Atlas access...

CTRE FAQ

What is CareTrust REIT, Inc. (CTRE)?CareTrust REIT, Inc. (CTRE) has a latest verified close of 41.13, down 0.02%, dated 6 Aug 2026. Use this page to check the price chart, company context, source-backed...

CareTrust REIT, Inc. (CTRE) has a latest verified close of 41.13, down 0.02%, dated 6 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.

What does Atlas show for CTRE?CareTrust REIT, Inc. (CTRE) has a latest verified close of 41.13, down 0.02%, dated 6 Aug 2026. It brings the latest available chart, company context, cited sources,...

CareTrust REIT, Inc. (CTRE) has a latest verified close of 41.13, down 0.02%, dated 6 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. Atlas files CTRE under USA Stocks, Healthcare & Medicine Stocks and Financial Stocks for browsing.

How often is the CTRE page updated?The CTRE public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...

The CTRE public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.

Which sources does Atlas use for CTRE?The CTRE file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NYSE:CTRE. SEC EDGAR provides the filing anchor for this issuer. The page separates verified...

The CTRE file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NYSE:CTRE. SEC EDGAR provides the filing anchor for this issuer. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.

Can Atlas run a full research brief on CTRE?Yes. The workstation can open CTRE, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.

Yes. The workstation can open CTRE, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.

Is this CTRE page investment advice?No. The CTRE page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...

No. The CTRE page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.

Methodology

This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.

Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.

Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →